Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-term follow-up of contemporary drug-eluting stent implantation in diabetic patients: Subanalysis of a randomized controlled trial.
van Hemert ND, Voskuil M, Rozemeijer R, Kraaijeveld AO, Rittersma SZ, Leenders GEH, Stein M, Frambach P, van der Harst P, Agostoni P, Stella PR; ReCre8 Study Investigators. van Hemert ND, et al. Among authors: leenders geh. Catheter Cardiovasc Interv. 2023 Feb;101(3):505-510. doi: 10.1002/ccd.30545. Epub 2023 Jan 18. Catheter Cardiovasc Interv. 2023. PMID: 36651339 Clinical Trial.
Randomized All-Comers Evaluation of a Permanent Polymer Zotarolimus-Eluting Stent Versus a Polymer-Free Amphilimus-Eluting Stent.
Rozemeijer R, Stein M, Voskuil M, van den Bor R, Frambach P, Pereira B, Koudstaal S, Leenders GE, Timmers L, Rittersma SZ, Kraaijeveld AO, Agostoni P, Roes KC, Doevendans PA, Stella PR; ReCre8 Study Investigators. Rozemeijer R, et al. Circulation. 2019 Jan 2;139(1):67-77. doi: 10.1161/CIRCULATIONAHA.118.037707. Circulation. 2019. PMID: 30586704 Clinical Trial.
One-year clinical outcomes of patients treated with polymer-free amphilimus-eluting stents or zotarolimus-eluting stents: A propensity-score adjusted analysis.
Rozemeijer R, van Muiden IG, Koudstaal S, Leenders GE, Timmers L, Rittersma SZ, Kraaijeveld AO, Doevendans PA, Voskuil M, Stella PR. Rozemeijer R, et al. Catheter Cardiovasc Interv. 2019 Jul 1;94(1):61-69. doi: 10.1002/ccd.28041. Epub 2019 Jan 2. Catheter Cardiovasc Interv. 2019. PMID: 30604493 Free PMC article.
Cost-effectiveness of the coronary sinus Reducer and its impact on the healthcare burden of refractory angina patients.
Gallone G, Armeni P, Verheye S, Agostoni P, Timmers L, Campo G, Ielasi A, Sgura F, Tarantini G, Rosseel L, Zivelonghi C, Leenders G, Stella P, Tebaldi M, Tespili M, D'Amico G, Baldetti L, Ponticelli F, Colombo A, Giannini F. Gallone G, et al. Eur Heart J Qual Care Clin Outcomes. 2020 Jan 1;6(1):32-40. doi: 10.1093/ehjqcco/qcz027. Eur Heart J Qual Care Clin Outcomes. 2020. PMID: 31124556
A pilot study with the TriGUARD 3 cerebral embolic protection device.
Magalhaes PG, Kooistra NHM, Leenders GEH, Margolis PM, Lansky AJ, Kraaijeveld AO, Voskuil M, Stella PR. Magalhaes PG, et al. Among authors: leenders geh. EuroIntervention. 2020 Aug 7;16(6):e507-e509. doi: 10.4244/EIJ-D-19-00741. EuroIntervention. 2020. PMID: 32091398 Free article. No abstract available.
Randomised comparison of a balloon-expandable and self-expandable valve with quantitative assessment of aortic regurgitation using magnetic resonance imaging.
Kooistra NHM, Abawi M, Voskuil M, Urgel K, Samim M, Nijhoff F, Nathoe HM, Doevendans PAFM, Chamuleau SAJ, Leenders GEH, Leiner T, Abrahams AC, van der Worp HB, Agostoni P, Stella PR. Kooistra NHM, et al. Among authors: leenders geh. Neth Heart J. 2020 May;28(5):253-265. doi: 10.1007/s12471-020-01414-0. Neth Heart J. 2020. PMID: 32246266 Free PMC article.
28 results